Published ahead of print on April 3, 2003, doi:10.1165/rcmb.2003-0035OC
Am. J. Respir. Cell Mol. Biol., Volume 29, Number 3, September 2003, 314-320
A more recent version of this article appeared on September 1, 2003
Submitted on February 4, 2003
Revised on April 2, 2003
Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice
Koichi Nagao1, Hiroyuki Tanaka1, Masato Komai1, Taisei Masuda1, Shuh Narumiya2, and Hiroichi Nagai1*
1 Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Gifu, Japan,
2 Department of Pharmacology, Kyoto University Faculty of Medicine, Kyoto, Kyoto, Japan
* To whom correspondence should be addressed. E-mail: nagai{at}gifu-pu.ac.jp.
Recently, we demonstrated that PGI2 has a regulatory role in allergic responses through the receptor, IP; however, the role of PGI2 in airway remodeling associated with chronic airway inflammation has not been elucidated. In the present study, we examined the role of PGI2 in allergen-induced airway remodeling using IP gene deficient mice. Mice were sensitized to ovalbumin (OA) with alum, and exposed daily for 3 weeks to aerosolized OA. Twenty-four h after the final antigen inhalation, bronchoalveolar lavage (BAL), biochemical and histopathological examinations were carried out. In wild-type mice, prolonged allergen exposure in sensitized animals induced the increases in the numbers of inflammatory leukocytes (including eosinophils and lymphocytes), levels of T helper type 2 (Th2) cytokines (IL-4, IL-5 and IL-13), levels of OA-specific IgE and IgG1 in
serum, and amount of hydroxyproline in the right lungs associated with transforming growth factor- 1 levels in BAL fluid. Moreover, goblet cell hyperplasia and subepithelial fibrosis were also appreciated after repeated allergen challenge. In contrast, the disruption of IP gene significantly augmented all these parameters. These findings suggest that PGI2 has a regulatory role in allergen-induced airway remodeling as well as airway
eosinophilic inflammation, Th2 cytokine production and IgE production, and that a PGI2 agonist is a therapeutic approach for the treatment of airway remodeling in allergic asthma.
This article has been cited by other articles:

|
 |

|
 |
 
W. Zhou, D. C. Newcomb, M. L. Moore, K. Goleniewska, J. F. O'Neal, and R. S. Peebles Jr.
Cyclooxygenase Inhibition during Allergic Sensitization Increases STAT6-Independent Primary and Memory Th2 Responses
J. Immunol.,
October 15, 2008;
181(8):
5360 - 5367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Locke, S. G. Royce, J. S. Wainewright, C. S. Samuel, and M. L. Tang
Comparison of Airway Remodeling in Acute, Subacute, and Chronic Models of Allergic Airways Disease
Am. J. Respir. Cell Mol. Biol.,
May 1, 2007;
36(5):
625 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhou, T. S. Blackwell, K. Goleniewska, J. F. O'Neal, G. A. FitzGerald, M. Lucitt, R. M. Breyer, and R. S. Peebles Jr.
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells
J. Leukoc. Biol.,
March 1, 2007;
81(3):
809 - 817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhou, K. Hashimoto, K. Goleniewska, J. F. O'Neal, S. Ji, T. S. Blackwell, G. A. FitzGerald, K. M. Egan, M. W. Geraci, and R. S. Peebles Jr.
Prostaglandin I2 Analogs Inhibit Proinflammatory Cytokine Production and T Cell Stimulatory Function of Dendritic Cells
J. Immunol.,
January 15, 2007;
178(2):
702 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Rothenberg, M. P. Doepker, I. P. Lewkowich, M. G. Chiaramonte, K. F. Stringer, F. D. Finkelman, C. L. MacLeod, L. G. Ellies, and N. Zimmermann
Cationic amino acid transporter 2 regulates inflammatory homeostasis in the lung
PNAS,
October 3, 2006;
103(40):
14895 - 14900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hirano, A. Kanehiro, K. Ono, W. Ito, A. Yoshida, C. Okada, H. Nakashima, Y. Tanimoto, M. Kataoka, E. W. Gelfand, et al.
Pirfenidone Modulates Airway Responsiveness, Inflammation, and Remodeling after Repeated Challenge
Am. J. Respir. Cell Mol. Biol.,
September 1, 2006;
35(3):
366 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L797 - L805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Peebles Jr, K. Hashimoto, J. R. Sheller, M. L. Moore, J. D. Morrow, S. Ji, J. A. Elias, K. Goleniewska, J. O'Neal, D. B. Mitchell, et al.
Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent
J. Immunol.,
December 15, 2005;
175(12):
8253 - 8259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hashimoto, B. S. Graham, M. W. Geraci, G. A. FitzGerald, K. Egan, W. Zhou, K. Goleniewska, J. F. O'Neal, J. D. Morrow, R. K. Durbin, et al.
Signaling through the Prostaglandin I2 Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness
J. Virol.,
October 1, 2004;
78(19):
10303 - 10309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanaka, M. Komai, K. Nagao, M. Ishizaki, D. Kajiwara, K. Takatsu, G. Delespesse, and H. Nagai
Role of Interleukin-5 and Eosinophils in Allergen-Induced Airway Remodeling in Mice
Am. J. Respir. Cell Mol. Biol.,
July 1, 2004;
31(1):
62 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|